




Christine Pellizzari - General Counsel & Corporate Secretary at Insmed, Inc.



























































                      NEWS HOME
                    

Advertising
Board and Executive Moves
Energy
Health Care
Hedge Funds
M & A
Private Equity
Technology








            You have  
            
9 free profiles

              left this month   
			      

                Start Your Free Trial ➤
              








            Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there?
            

                View on RelSci Pro ➤
              




























































































































Email







LinkedIn







Facebook







Google+







Tweet







Reddit





Permalink





Christine Pellizzari
General Counsel & Corporate Secretary at Insmed, Inc.



Overview
In The News Relationships Paths
Education Memberships Career History Public Holdings Transactions 


Christine Pellizzari
General Counsel & Corporate Secretary at Insmed, Inc.



 Overview



Age



49
                                  (Born 1968)
                                              




Notable Companies


Insmed, Inc.

Aegerion Pharmaceuticals Inc.

Dendrite International, Inc.




Number of Relationships



                This person is connected to 951 people.
              






 In The News
          See more




PR Newswire
April 10, 2013





                        American Standard Brands' Executive Named as Finalist for General Counsel of Year                    





PR Newswire
April 10, 2013





                        American Standard Brands' Executive Named as Finalist for General Counsel of Year.                    





PR Newswire
April 1, 2013





                        NJBIZ Honors New Jersey's General Counsels.                    





PR Newswire
April 1, 2013





                        NJBIZ Honors New Jersey's General Counsels                    







 Relationships
              See Details




Andrew P. Gilbert

Co-Managing Partner at DLA Piper




Will Lewis

President & Chief Executive Officer at Insmed, Inc.





Jocelyn M. Arel

Partner at Goodwin Procter LLP




Michael H. Bison

Partner at Goodwin Procter LLP





Walter Perkins

Chief Technology Officer at Insmed, Inc.




Renu Vijaya

Executive Vice President & Chief Medical Officer at Insmed, Inc.





Paolo Tombesi

Chief Financial Officer at Insmed, Inc.




Roger Adsett

Chief Commercial Officer at Insmed, Inc.





Susan Mesco

Head, Investor Relations at Insmed, Inc.




Andrew T. Drechsler

Former Chief Financial Officer at Insmed, Inc.







See 941 more listings with RelSci Professional.

Start My Free Trial ➤








See 941 More 


 


 Paths to Christine Pellizzari



            Christine Pellizzari          




 You



 Connections via Relationship Science



 Christine Pellizzari






Sync your contacts to see how you can connect with Christine Pellizzari.

Start My Free Trial ➤








See  More 


 


 Educational Background



Bachelor of Arts in Legal Studies 


University of Massachusetts - Amherst

                  UMass Amherst, the flagship campus of the University of Massachusetts system, sits on nearly 1,450-acres in the scenic Pioneer Valley of Western Massachusetts, 90 miles from Boston and 175 miles from New York City. The campus provides a rich cultural environment in a rural setting close to major urban centers.                




Juris Doctorate 


University of Colorado School of Law

                  The University of Colorado Law School is one of the top public law schools in the United States. 
    Established in 1892 in Boulder, Colorado
    Diverse student body from over 100 undergraduate institutions
    Highly published faculty 
    State-of-the-art Wolf Law Building (LEED Gold certified)
    551 students 
    9.68 to 1 student to faculty ratio
    Thriving academic community                





 Memberships



Member

                  Current                


Association of Corporate Counsel

                  The Association of Corporate Counsel (ACC), originally founded as the American Corporate Counsel Association (ACCA) in 1983, is a professional association serving the business interests of attorneys who practice in the legal departments of corporations, associations and other private-sector organizations around the world. ACC states that it has more than 34,000 members employed by over 10,000 organizations in 85 countries.                




Member

                  Current                


Society of Corporate Secretaries and Governance Professionals, Inc.

                  Founded in 1946, the Society of Corporate Secretaries and Governance Professionals, Inc. (the "Society") is a non-profit organization (Section 501(c)(6)) comprised principally of corporate secretaries and business executives in governance, ethics and compliance functions at public, private and not-for-profit organizations. Members are responsible for supporting their board of directors and executive management in matters such as board practices, compliance, regulation and legal matters, shareholder relations and subsidiary management.                




Member

                  Current                


National Association of Stock Plan Professionals

                  The National Association of Stock Plan Professionals is committed to providing services to its members that will enrich their professional skills, further their professional knowledge and, in general, enhance the stock plan profession at every level. The Association provides opportunities for education, networking and information exchange through its national office, local chapters and national and local conferences. Members are professionals whose responsibilities are related, directly or indirectly, to stock plan administration and design.

The Association strives to provide leadership in helping members to develop effective business and work practices for the benefit of themselves and their companies or firms; assist members in achieving and maintaining the highest professional standards; and, where and when appropriate, act as an advocate for the membership on significant issues affecting the stock plan industry.                





 Career History



General Counsel & Corporate Secretary

                                    2013 - Current                


Insmed, Inc.


                  Insmed, Inc. operates as a biopharmaceutical company focused on developing and commercializing inhaled therapies for patients battling serious lung diseases that are often life threatening. It focuses on the development and commercialization of ARIKAYCE or liposomal amikacin for inhalation (LAI), for at least two identified orphan patient populations: patients with nontuberculous mycobacteria lung disease and cystic fibrosis patients with Pseudomonas aeruginosa lung infections. The company was founded on November 29, 1999 and is headquartered in Bridgewater, NJ.                




Secretary, Executive Vice President & General Counsel

                                    2007 - 2012                


Aegerion Pharmaceuticals Inc.


                  Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of innovative therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer and William H. Lewis on February 4, 2005 and is headquartered in Cambridge, MA.                




Secretary, Senior Vice President & General Counsel

                                    1998 - 2007                


Dendrite International, Inc.


                  Dendrite International, Inc. provides sales force software products and support services. It offers technological tools, databases, and data flow management services. The company provides services to the pharmaceutical, life sciences, and healthcare industries. Dendrite International was founded by John E. Bailye in 1986 and is headquartered in Bedminster, NJ.                




Associate

                                    1995 - 1998                


Wilentz, Goldman & Spitzer PA






Law Clerk

                                    1994 - 1998                


New Jersey Superior Court







 Public Holdings






Restricted data only for RelSci Professional users.

Start My Free Trial ➤








See  More 


 


 Transactions



 Details Hidden



                  Insmed, Inc. issued Common Stock                                  




 Details Hidden



                  Insmed, Inc. issued Common Stock                                  




 Details Hidden



                  Aegerion Pharmaceuticals Inc. issued Common Stock                                  




 Details Hidden



                  Aegerion Pharmaceuticals Inc. issued Common Stock                                  




 Details Hidden



                  Aegerion Pharmaceuticals Inc. raised money in a private placement transaction                                  






See 1 more listing with RelSci Professional.

Start My Free Trial ➤








See 1 More 






 Other Affiliations




              Christine Pellizzari is affiliated with
                            Insmed, Inc., Aegerion Pharmaceuticals Inc., Dendrite International, Inc., Wilentz, Goldman & Spitzer PA, New Jersey Superior Court.
            





You've reached your 10 free profiles limit this month.
Upgrade to RelSci Pro today to enjoy unlimited article views and much more!

Start My Free Trial  ➤

Still not convinced? Check out our full listing of features here.












Are you a RelSci Pro Subscriber?

Login to RelSci Pro 
                        ➤


Not a Pro Subscriber? Log in here to manage your alerts









 Keep me signed in.
        

Login  ➤



        Forgot your Password?
    

























 I have read the LexisNexis terms & conditions




Sign Me Up  ➤
















Insmed Appoints Christine Pellizzari as General Counsel and Corporate Secretary (NASDAQ:INSM)


























 



Facebook
Google
LinkedIn
Twitter
Email
RSS





Jul 29, 2013



 Previous Release | Next Release 


PDF


Insmed Appoints Christine Pellizzari as General Counsel and Corporate Secretary
20 Year Industry Veteran Brings Broad Legal and Leadership Experience in Development and Commercial Stage Biopharmaceutical Companies

MONMOUTH JUNCTION, NJ -- (Marketwired) -- 07/29/13 --

 Insmed Incorporated (NASDAQ: INSM) a biopharmaceutical company focused on developing and commercializing an inhaled anti-infective to treat patients battling serious lung diseases that are often life-threatening, today announced the appointment of Christine A. Pellizzari as General Counsel and Corporate Secretary. 
Ms. Pellizzari joins Insmed with nearly 20 years of senior-level leadership experience in the global biotechnology and pharmaceutical industry. Prior to joining Insmed, Ms. Pellizzari was with Aegerion Pharmaceuticals, Inc. from 2007 to 2012, where she served as Executive Vice President, General Counsel and Corporate Secretary. Among her accomplishments and responsibilities at Aegerion, Ms. Pellizzari oversaw all the legal aspects of that company's successful IPO and secondary public offering and served as a member of the Executive Management Committee. Prior to that, from 1998 to 2007, Ms. Pellizzari was Senior Vice President, General Counsel and Corporate Secretary at Dendrite, Inc., a Nasdaq-listed, leading provider of 
sales and marketing solutions to the pharmaceutical industry with over $400 million in annual revenue and more than 2,500 employees in 25 countries that was acquired by Cegedim, S.A. for $750 million in May 2007. 
"I am particularly pleased to welcome Christine to the Insmed team. Having worked with Christine while at Aegerion, I know first-hand that she will be an invaluable asset to the Company. Christine has broad legal experience with both development and commercial stage pharmaceutical companies. Her significant leadership experience will provide new insight and valuable perspective as we look to transition the Company to a commercial entity and build Insmed into a leading biopharmaceutical company," said Will Lewis, President and CEO of Insmed. 
"It is a pleasure to be joining the Insmed team at this important juncture in the Company's development. The Company's focus on developing new therapeutics for unmet medical needs at the intersection of pulmonary, infectious and orphan diseases offers a very exciting opportunity. I look forward to being a part of this dynamic leadership team as we bring new treatments to patients suffering from these serious lung diseases," commented Ms. Pellizzari. 
Before joining Dendrite, Ms. Pellizzari was an Associate in the Corporate and Healthcare Departments at Wilentz, Goldman & Spitzer from 1996 to 1998. From 1994 to 1995, Ms. Pellizzari was a law clerk to the Honorable Reginald Stanton in the Superior Court of New Jersey, Morris and Sussex Vicinages. 
Ms. Pellizzari received her Juris Doctor from the University of Colorado School of Law (Boulder, CO) and her Bachelor of Arts in Legal Studies from the University of Massachusetts (Amherst, MA), where she graduated cum laude. Ms. Pellizzari is a member of the New Jersey Bar.
About Insmed 
Insmed Incorporated is a biopharmaceutical company dedicated to improving the lives of patients battling serious lung diseases. Insmed is focused on the development and commercialization of ARIKACE®, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: cystic fibrosis (CF) patients with Pseudomonas aeruginosa lung infections and patients with non-tuberculous mycobacteria (NTM) lung infections. For more information, visit www.insmed.com. 
Forward-looking statements:
This release contains forward-looking statements. Words, and variations of words, such as "intend," "expect," "will," "anticipate," "believe," "continue," "propose" and similar expressions are intended to identify forward-looking statements. Investors are cautioned that such statements in this release, including statements relating to the status, results and timing of clinical trials and clinical data, the anticipated benefits of Insmed's products, the anticipated timing of regulatory submissions, and the ability to obtain required regulatory approvals, bring products to market and successfully commercialize products constitute forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties 
include, without limitation, failure or delay of European, Canadian, U.S. Food and Drug Administration and other regulatory reviews and approvals, competitive developments affecting the Company's product candidates, delays in product development or clinical trials or other studies, patent disputes and other intellectual property developments relating to the Company's product candidates, unexpected regulatory actions, delays or requests, the failure of clinical trials or other studies or results of clinical trials or other studies that do not meet expectations, the fact that subsequent analyses of clinical trial or study data may lead to different (including less favorable) interpretations of trial or study results or may identify important implications of a trial or study that are not reflected in Company's prior disclosures, and the fact that trial or study results or 
subsequent analyses may be subject to differing interpretations by regulatory agencies, the inability to successfully develop the Company's product candidates or receive necessary regulatory approvals, inability to make product candidates commercially successful, changes in anticipated expenses, changes in the Company's financing requirements or ability raise additional capital, and other risks and challenges detailed in the Company's filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2012. Investors are cautioned not to place undue reliance on any forward-looking statements that speak only as of the date of this news release. The Company undertakes no obligation to update these forward-looking statements to reflect events or circumstances or changes in its expectations.

Contacts:

LHA 
Anne Marie Fields 

Senior Vice President

212-838-3777
afields@lhai.com 

Bruce Voss

Managing Director

310-691-7100
bvoss@lhai.com

Source: Insmed Incorporated 

News Provided by Acquire Media








 





Christine A Pellizzari - Sea Girt, NJ | Intelius



























Sign In



We found Christine A Pellizzari in Sea Girt, NJ


Christine A Pellizzari

                                                                                       Intelius found that Christine A Pellizzari  is  a female between 40 and 50 years old from Sea Girt, NJ.  We have connected them to
                18 addresses,
                10 phones,
                and 5 relatives or associates.
         





Also Known As

Christine Annette Pellizzari
Christi  Rubinstein
Christine  Rubinstein
Christine Steven Ru Pellizzari


Get Report Now

Age

Christine A Pellizzari is in her 40s

Christine Has Lived In

Sea Girt, NJ
Manasquan, NJ
Morristown, NJ

Christine's Relatives

Steven Rubinstein
John Pellizzari
Mary Pellizzari
Alissa Pellizzari







Christine A Pellizzari



Zodiac SignScorpio



GenderFemale



Professional Status
General Counsel at Insmed Incorporated



Get Report Now










Want to know more about Christine? Get a comprehensive background report, find full phone numbers, and other contact information when available, all from billions of available public records.
            Continue below for more details about Christine, or use our people search engine to find others.
Get Background Check on Christine A Pellizzari
Get a Criminal Check on Christine A Pellizzari
Get a Public Record Report on Christine A Pellizzari
Get a People Search Report on Christine A Pellizzari


Christine A Pellizzari's Contact Information
Known Cities Lived In
Find out where Christine A Pellizzari has lived as well as Christine A Pellizzari's phone numbers and email addresses.




Christine A Pellizzari Has Lived in 4 States
New Jersey Address for Christine A Pellizzari


300 B******** B*** 

Sea Girt, NJ


Has Lived In

Sea Girt, NJ
Manasquan, NJ


Get Full Address Report










Phone Numbers Associated with Christine A Pellizzari

(732) ***-**** - Sea Girt, NJ 
(617) ***-**** - Cambridge, MA 
(732) ***-**** - Woodbridge, NJ 


Get Full Phone Report



Email Addresses Associated with Christine A Pellizzari

c*********i@***.com
c*********i@***.com
c**********i@***.com


Get Email Report




Christine A Pellizzari's Education Information
Known Schools Attended
Learn about Christine A Pellizzari's academic history.  Find out which schools Christine A Pellizzari attended, the dates attended as well as the degrees Christine A Pellizzari received.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Christine A Pellizzari Has Attended 4 Schools
University of Colorado School of Law 1991 – 1994                              
University of Massachusetts, Amherst               1985 – 1989               Christine A Pellizzari has a B.A. in Legal Studies, History, English               
University of Massachusetts, Amherst               1985 – 1989               Christine A Pellizzari has a B.a., in Legal Studies, History, English               
University of Massachusetts, Amherst               1985 – 1989               Christine A Pellizzari has a B.a., Legal Studies, History, English in Legal Studies               


Christine A Pellizzari's Professional Information
Information regarding Christine A Pellizzari's professional history.  Find out previous places Christine A Pellizzari has worked as well as dates employed.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Christine A Pellizzari Has Worked at 14 Places
Company: Insmed Incorporated
               Title: General Counsel
Company: Insmed Incorporated
               Title: Vice President Business Development
Christine A Pellizzari's Experience
Title: General Counsel
               Company: Insmed Incorporated
Job Details
               Company Size: $10 mil to less than $25 mil - Employee Range: 100 to less than 500
Title: Vice President Business Development
               Company: Insmed Incorporated
Job Details
               Company Size: $10 mil to less than $25 mil - Employee Range: 100 to less than 500
Additional Professional Information on Christine A Pellizzari

 See Christine A Pellizzari's LinkedIn Profile



Christine A Pellizzari's Social Network and Potential Email Matches
Find out potential social network profiles and potential email usernamed for Christine A Pellizzari


Christine A Pellizzari's known Social Networks And Potential Email Matches

Find all of Christine A Pellizzari's Social Network Profiles

Get Full Report

Search Social Networks
Including Facebook, LinkedIn, MySpace, Google, Twitter, Yahoo, Jigsaw, ZoomInfo and more



Potential Email Matches
Christine Pellizzari
Username Matches

                  ChristinePellizzari
                  PellizzariChristine
                  Christine.Pellizzari
                  Pellizzari.Christine
                  Christine_Pellizzari
                  Pellizzari_Christine
                  Christine-Pellizzari
                  Pellizzari-Christine
                  CPellizzari
               


Popular Email Services

@gmail.com
@aol.com
@yahoo.com
@comcast.net
@hotmail.com
@msn.com
@rocketmail.com
@att.net
@sbcglobal.net
@ymail.com
@facebook.com
@mail.com
@bellsouth.net
@live.com
@earthlink.net
@cox.net
@prodigy.net
@me.com
@peoplepc.com
@juno.com
@rediffmail.com
@mindspring.com
@comcast.com
@charter.net
@outlook.com




All trademarks, product names, company names or logos on this page are the property of their respective owners.
Related People Searches
C Pellizzari







         Intelius is a leading provider of public data about people and their connections to others. Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the Fair Credit Reporting Act (FCRA). This site should not be used to determine an individual’s eligibility for credit, insurance, employment, housing or any other purpose covered by the FCRA. For employment or tenant screening services, please visit our partner Talentwise.
      

About Us
Site Map
About Our Reports
Blog
Help
Contact Us

© 2003 – 2017 PeopleConnect, Inc. d/b/a Intelius. All Rights Reserved.
         Privacy Policy - UPDATED
Terms of Service - UPDATED






What is the FCRA?
The Fair Credit Reporting Act ("FCRA") is a federal law that promotes the accuracy, fairness and privacy of information in the files of consumer reporting agencies.
Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the FCRA. Intelius reports cannot be used for background checks related to consumer credit, insurance, employment, housing or any other purpose
                  prohibited under the FCRA.
You may not use any information obtained from Intelius for any purpose covered by the FCRA.
Find out more about the FCRA here.











Insmed Appoints Christine Pellizzari as General Counsel and Corporate SecretaryHomeMailFlickrTumblrNewsSportsFinanceCelebrityAnswersGroupsMobileMoreTry Yahoo Finance on Firefox »YahooSearchSearchSign inU.S. Markets closedS&P 5002,469.91-2.63 (-0.11%)Dow 3021,513.17-66.90 (-0.31%)Nasdaq6,410.81+23.05 (+0.36%)Insmed Appoints Christine Pellizzari as General Counsel and Corporate SecretaryMarketwiredJuly 29, 2013ReblogShareTweetShareMONMOUTH JUNCTION, NJ--(Marketwired - Jul 29, 2013) - Insmed Incorporated (  NASDAQ :  INSM ) a biopharmaceutical company focused on developing and commercializing an inhaled anti-infective to treat patients battling serious lung diseases that are often life-threatening, today announced the appointment of Christine A. Pellizzari as General Counsel and Corporate Secretary.Ms. Pellizzari joins Insmed with nearly 20 years of senior-level leadership experience in the global biotechnology and pharmaceutical industry. Prior to joining Insmed, Ms. Pellizzari was with Aegerion Pharmaceuticals, Inc. from 2007 to 2012, where she served as Executive Vice President, General Counsel and Corporate Secretary. Among her accomplishments and responsibilities at Aegerion, Ms. Pellizzari oversaw all the legal aspects of that company's successful IPO and secondary public offering and served as a member of the Executive Management Committee. Prior to that, from 1998 to 2007, Ms. Pellizzari was Senior Vice President, General Counsel and Corporate Secretary at Dendrite, Inc., a Nasdaq-listed, leading provider of sales and marketing solutions to the pharmaceutical industry with over $400 million in annual revenue and more than 2,500 employees in 25 countries that was acquired by Cegedim, S.A. for $750 million in May 2007."I am particularly pleased to welcome Christine to the Insmed team. Having worked with Christine while at Aegerion, I know first-hand that she will be an invaluable asset to the Company. Christine has broad legal experience with both development and commercial stage pharmaceutical companies. Her significant leadership experience will provide new insight and valuable perspective as we look to transition the Company to a commercial entity and build Insmed into a leading biopharmaceutical company," said Will Lewis, President and CEO of Insmed."It is a pleasure to be joining the Insmed team at this important juncture in the Company's development. The Company's focus on developing new therapeutics for unmet medical needs at the intersection of pulmonary, infectious and orphan diseases offers a very exciting opportunity. I look forward to being a part of this dynamic leadership team as we bring new treatments to patients suffering from these serious lung diseases," commented Ms. Pellizzari.Before joining Dendrite, Ms. Pellizzari was an Associate in the Corporate and Healthcare Departments at Wilentz, Goldman & Spitzer from 1996 to 1998. From 1994 to 1995, Ms. Pellizzari was a law clerk to the Honorable Reginald Stanton in the Superior Court of New Jersey, Morris and Sussex Vicinages.Ms. Pellizzari received her Juris Doctor from the University of Colorado School of Law (Boulder, CO) and her Bachelor of Arts in Legal Studies from the University of Massachusetts (Amherst, MA), where she graduated cum laude. Ms. Pellizzari is a member of the New Jersey Bar.About InsmedInsmed Incorporated is a biopharmaceutical company dedicated to improving the lives of patients battling serious lung diseases. Insmed is focused on the development and commercialization of ARIKACE®, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: cystic fibrosis (CF) patients with Pseudomonas aeruginosa lung infections and patients with non-tuberculous mycobacteria (NTM) lung infections. For more information, visit www.insmed.com.Forward-looking statements:This release contains forward-looking statements. Words, and variations of words, such as "intend," "expect," "will," "anticipate," "believe," "continue," "propose" and similar expressions are intended to identify forward-looking statements. Investors are cautioned that such statements in this release, including statements relating to the status, results and timing of clinical trials and clinical data, the anticipated benefits of Insmed's products, the anticipated timing of regulatory submissions, and the ability to obtain required regulatory approvals, bring products to market and successfully commercialize products constitute forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, without limitation, failure or delay of European, Canadian, U.S. Food and Drug Administration and other regulatory reviews and approvals, competitive developments affecting the Company's product candidates, delays in product development or clinical trials or other studies, patent disputes and other intellectual property developments relating to the Company's product candidates, unexpected regulatory actions, delays or requests, the failure of clinical trials or other studies or results of clinical trials or other studies that do not meet expectations, the fact that subsequent analyses of clinical trial or study data may lead to different (including less favorable) interpretations of trial or study results or may identify important implications of a trial or study that are not reflected in Company's prior disclosures, and the fact that trial or study results or subsequent analyses may be subject to differing interpretations by regulatory agencies, the inability to successfully develop the Company's product candidates or receive necessary regulatory approvals, inability to make product candidates commercially successful, changes in anticipated expenses, changes in the Company's financing requirements or ability raise additional capital, and other risks and challenges detailed in the Company's filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2012. Investors are cautioned not to place undue reliance on any forward-looking statements that speak only as of the date of this news release. The Company undertakes no obligation to update these forward-looking statements to reflect events or circumstances or changes in its expectations.ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextHIV fight advances with new drug cocktails, fresh vaccine hopesReutersKKR to buy WebMD in $2.8 billion dealReutersDemocrats take aim at big companies in economic blueprintReutersDems to announce 'better deal' plansCNBC VideosAlphabet shares drop after it reports lower profit on huge EU fineCNBCObamacare is hurting these people—and Congress is doing nothing about itYahoo FinanceWhy scientists want AI regulated now before it's too lateDan HowleySaudi Arabia Turns Off the U.S. Oil TapBloombergChina is crushing American tech titansYahoo Finance VideoStocks rangebound ahead of big earningsYahoo FinanceFix My Finances: I borrowed from my 401(k)Yahoo FinanceSome of the most powerful people in the US are talking about a massive change to healthcareBusiness InsiderNvidia Corporation (NVDA) Stock Is No Longer the Best Play on AIInvestorPlaceJohn McAfee reportedly lands in hospital after attackZDNetGoogle's forward guidance trumps earnings any day: NYSE traderYahoo Finance VideoEarnings won't matter if Q2 GDP disappoints investorsYahoo FinanceJohn Dean: As the Russia Investigation Closes In on the Trump Family, Can Mueller Be Fired?Dennis: It's become increasingly obvious that the remaining Trump supporters don't actually care if he's a criminal--not so long as they think he's THEIR criminal. Of course, even the notion that he's on "their side" is laughable.Join the Conversation1 / 5210








   Christine Pellizzari | Aegerion Pharmaceuticals, Inc. | ZoomInfo.com


Christine A. Pellizzari - 908.541-5969 / +1-908.541-5969 - 908.541-5800 / +1-908.541-5800 - MoreOpp.com




















Add Company

Add (Buy/Sale/Service)






New Jersey
Christine A. Pellizzari

Home > New Jersey > Christine A. Pellizzari


ContactDescription



Christine A. Pellizzari



Phone:
908.541-5800 / +1-908.541-5800
Email:
908.541-5969 / +1-908.541-5969


International Area Code:
+1
Phone:
908.541-5800 / +1-908.541-5800
Fax:
908.541-5969 / +1-908.541-5969
Street:
200 Somerset Corporate Boulevard
Locality:
Bridgewater
State:
NJ
ZIP Code:
08807
Country:
USA
Web Sites:


[Add Company] [Request Update] [Request Remove]




Share this Company













DescriptionContact





Company Name:
Christine A. Pellizzari
Products & Servcies:
Legal and Finances:Law Firms:Contracts, Corporate Law, Intellectual Property, Labor and Employment, Mergers and Acquisitions, Real Estate, Securities
Contact Names & Positions:

Year of Establish:

Employees:

Category:
Legal and Finances: Lawyers, Attorneys

Christine A. Pellizzari is a New Jersey company, located in 200 Somerset Corporate Boulevard; Bridgewater; NJ; 08807, 








Previous:Christina Silva Lee
Next:Christine M. Gravelle











Bravo Messenger Service
Celebrant Foundations & Institute
Welcome to the Celebrant Foundation and Institute! We are the preeminent, global online institute teaching and certifying people to be a Life-Cycle Celebrant® who are modern day personalized ceremony professionals. ThrouAll Seasons Quality Renovations
All Seasons Quality Renovations is a full-service, residential contractor which offers a wide array of home improvement services like kitchens renovation, bathrooms, additions, insulation, roofing, windows, siding, home  


Related companies

Christina I.K. Hawkes
Christina I.K. Hawkes is a New Jersey company, located in 3000 Continental Drive North; Mount Olive; NJ; 07828-1234, Christina M. Manuelli
Christina M. Manuelli is a New Jersey company, located in 136 Main Street, Suite 250; Princeton; NJ; 08540-5799, Christine A. Amalfe
Christine A. Amalfe is a New Jersey company, located in One Riverfront Plaza; Newark; NJ; 07102, Cheryl L. Di Bona
Cheryl L. Di Bona is a New Jersey company, located in 136 Main Street, Suite 250; Princeton; NJ; 08540-5799, Christine F. Li
Christine F. Li is a New Jersey company, located in Metro Corporate Campus I, P.O. Box 5600; Woodbridge; NJ; 07095-0988,  





Buyer
Alaska
Alabama
Arkansas
Arizona
California
Colorado
Connecticut
District Of Columbia
Delaware
Florida
Georgia
Hawaii
Iowa
Idaho
Illinois
Indiana
Kansas
Kentucky
Louisiana
Massachusetts
Maryland
Maine
Michigan
Minnesota
Missouri
Mississippi
Montana



North Carolina
North Dakota
Nebraska
New Hampshire
New Jersey
New Mexico
Nevada
New York
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Virginia
Vermont
Washington
Wisconsin
West Virginia
Wyoming


















需要安全验证




Facebook加入或登录 Facebook   邮箱或手机号密码忘记帐户？登录想加入 Facebook 吗？注册注册安全验证码请输入以下文本看不清楚上面的文字？换一个或播放语音验证信息框中文字：这是什么？安全验证这是一个标准的安全测试，用于阻止垃圾邮件制造者创建假帐户并向用户发送垃圾信息。提交中文(简体)English (US)日本語한국어Français (France)Bahasa IndonesiaPolskiEspañolPortuguês (Brasil)DeutschItalianoMessengerFacebook Lite用户地点游戏位置名人二手市场小组食谱彩色气球Instagram公司简介创建广告创建主页开发者招聘信息隐私权政策Cookie广告选项条款设置活动日志 Facebook © 2017





PELLIZZARI CHRISTINE A Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      PELLIZZARI CHRISTINE A
                    

•   BRIDGEWATER, NJ
                      
How do I update this listing?




                                             Pellizzari Christine A is based out of Bridgewater.   
                                           














Summary
13D/G
Insider (Form 4)



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from PELLIZZARI CHRISTINE A, enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




pellizzari christine a


10 FINDERNE AVENUE

BRIDGEWATER
NJ
                                                        
                                                    08807









Recent SEC Filings




4 filed on 06/01/2017
4 filed on 05/19/2017
4 filed on 01/09/2017
4 filed on 12/16/2016
4 filed on 05/23/2016
4 filed on 01/11/2016
4 filed on 05/26/2015
4 filed on 01/09/2015
4 filed on 06/04/2014
4 filed on 01/14/2014
















Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...








Elevate your investments
Try it for free




















INSM Christine A. Pellizzari Insider Trades for Insmed Inc.


































Bulletin






Investor Alert







Tokyo Markets Open in:



US Market Snapshot
Currencies
Commodities


















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Insmed Inc.

                  NASDAQ: INSM
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Insmed Inc.



After Hours
 --Quotes are delayed by 20 min
Jul 24, 2017, 5:20 p.m.


INSM

/quotes/zigman/4240070/composite


$
17.35




Change

0.00
0.00%

Volume
Volume 7,277
Quotes are delayed by 20 min








/quotes/zigman/4240070/composite
Today's close

$
			17.31
		


$
				17.35
			
Change

+0.04
+0.23%





Day low
Day high
$16.93
$17.51










52 week low
52 week high

            $10.21
        

            $19.35
        


















Insider Activity


Individual




Christine A. Pellizzari



Ms. Christine A. Pellizzari is Secretary & General Counsel at Insmed, Inc., a Member at Association of Corporate Counsel, a Member at Society of Corporate Secretaries & Governance Professionals, and a Member at National Association of Stock Plan Professionals.
Ms. Pellizzari was previously employed as Secretary, Executive VP & General Counsel by Aegerion Pharmaceuticals, Inc., Secretary, Senior Vice President & General Counsel by Dendrite International, Inc., and an Associate by Wilentz, Goldman & Spitzer PA.
She received her undergraduate degree from the University of Massachusetts and a graduate degree from The University of Colorado.



Transactions


Date
Shares
Transaction
Value





05/31/2017
2,700


 
Acquisition at $14.89 per share.


40,203


05/30/2017
7,300


 
Acquisition at $15.23 per share.


111,179


12/15/2016
10,000


 
Acquisition at $12.89 per share.


128,900


12/14/2016
10,000


 
Acquisition at $12.72 per share.


127,200





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Mr. William H. Lewis 
President, Chief Executive Officer & Director




Mr. Paolo  Tombesi 
Chief Financial Officer




Dr. Paul  Streck 
Chief Medical Officer




Dr. Walter R. Perkins 
Chief Technology Officer




Dr. Eugene Jeffrey Sullivan 
Chief Product Strategy Officer




Mr. Roger  Adsett 
Chief Commercial Officer




Mr. John  Goll 
Vice President & Corporate Controller




Ms. Susan  Mesco 
Head-Investor Relations




Ms. S. Nicole Schaeffer 
Senior VP-Human Resources & Corporate Services




Ms. Christine A. Pellizzari 
Secretary & General Counsel




Mr. Donald J. Hayden 
Non-Executive Chairman




Mr. David Richard Brennan 
Independent Director




Ms. Myrtle S. Potter 
Independent Director




Dr. Steinar Johan Engelsen 
Independent Director




Dr. Melvin  Sharoky 
Independent Director




Mr. David W. J. McGirr 
Independent Director




Mr. Alfred F. Altomari 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




6:05 PM EDT
July 24, 2017


/marketstate/country/us
New York

	After


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
6:01pAlphabet falls after earnings beat: Live blog
5:48pIs Kushner's Statement a Turning Point for Trump Team?
5:35pIs this why United, TSA clashed on Twitter over comic books on planes?
5:16p30-year Treasury yield snaps six-day streak of declines
5:05pCompanies do better when CEO pay dwarfs average worker, study finds
5:04pAnadarko shares down 3% after company posts wider-than-expected loss
5:00pAlphabet falls after earnings beat: Live blog
4:55pTrump Pushes GOP for Affordable Care Act Repeal
4:52pU.S. will go single-payer route on health care: Jimmy Carter
4:48pThe scientifically proven reason you should stop feeling guilty about ordering takeout
4:45pNasdaq closes at record as tech stocks shake off broader weakness
4:41pWatch out for these surprise charges at the ER
4:35pHere’s a sign investors are viewing earnings through rose-tinted glasses
4:34pMcDonald’s earnings: Sales expected to be boosted by menu, franchisee changes
4:31pTrump Today: President asks why ‘beleaguered’ Sessions isn’t probing Clinton    
4:23pArgentina ETF sees steep outflows amid strong gains
12:56pOpinion Journal: Congress's Russia Sanctions Calculus
12:55pOpinion Journal: Robert Mueller’s Power Play
12:52pOpinion Journal: Joseph Rago 
12:38pOpinion Journal: Americans Abroad: Beware  
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,513.17

-66.90
-0.31%





nasdaq

/quotes/zigman/12633936/realtime
6,410.81

+23.05
+0.36%





s&p 500

/quotes/zigman/3870025/realtime
2,469.91

-2.63
-0.11%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15






















































